{"organizations": [], "uuid": "871ea5e271e9b56fe763a7a455918ec351857dc1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-glaxosmithkline-says-updated-marke/brief-glaxosmithkline-says-updated-marketing-authorisation-by-european-commission-will-be-reflected-in-label-for-relvar-ellipta-idUSFWN1QQ08X", "country": "US", "domain_rank": 408, "title": "BRIEF-Glaxosmithkline Says Updated Marketing Authorisation By European Commission Will Be Reflected In Label For Relvar Ellipta", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-08T10:10:00.000+02:00", "replies_count": 0, "uuid": "871ea5e271e9b56fe763a7a455918ec351857dc1"}, "author": "", "url": "https://www.reuters.com/article/brief-glaxosmithkline-says-updated-marke/brief-glaxosmithkline-says-updated-marketing-authorisation-by-european-commission-will-be-reflected-in-label-for-relvar-ellipta-idUSFWN1QQ08X", "ord_in_thread": 0, "title": "BRIEF-Glaxosmithkline Says Updated Marketing Authorisation By European Commission Will Be Reflected In Label For Relvar Ellipta", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-glaxosmithkline says updated marketing", "sentiment": "negative"}, {"name": "european commission will be reflected in label for relvar ellipta reuters staff", "sentiment": "none"}, {"name": "glaxosmithkline plc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 8, 2018 / 8:11 AM / Updated 24 minutes ago BRIEF-Glaxosmithkline Says Updated Marketing Authorisation By European Commission Will Be Reflected In Label For Relvar Ellipta Reuters Staff 1 Min Read March 8 (Reuters) - Glaxosmithkline Plc: * UPDATED MARKETING AUTHORISATION BY EUROPEAN COMMISSION WILL BE REFLECTED IN LABEL FOR RELVAR ELLIPTA FOR COUNTRIES IN EUROPEAN UNIONâ€‹ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)", "external_links": [], "published": "2018-03-08T10:10:00.000+02:00", "crawled": "2018-03-08T10:40:42.068+02:00", "highlightTitle": ""}